Determinants of adverse outcomes following patent foramen ovale closure in elderly patients
Julio I Farjat-Pasos,Paul Guedeney,Eric Horlick,Jeremie Abtan,Luis Nombela-Franco,Benjamin Hibbert,Lars Sondergaard,Xavier Freixa,Jean-Bernard Masson,Ignacio Cruz-González,Rodrigo Estévez-Loureiro,Laurent Faroux,Ashish H Shah,Lusine Abrahamyan,Jules Mesnier,Adrián Jerónimo,Omar Abdel-Razek,Troels Højsgaard Jørgensen,Mike Al Asmar,Samuel Sitbon,Mohammed Abalhassan,Mathieu Robichaud,Christine Houde,Mélanie Côté,Angel Chamorro,Sylvain Lanthier,Steve Verreault,Gilles Montalescot,Josep Rodés-Cabau
DOI: https://doi.org/10.4244/EIJ-D-24-00156
2024-08-19
EuroIntervention
Abstract:Background: Limited data are available on transcatheter patent foramen ovale (PFO) closure outcomes in the elderly. Aims: Through this study, we aimed to determine the incidence and predictors of adverse events (recurrent cerebrovascular events [CVE] and atrial fibrillation [AF]) post-PFO closure in older patients with cryptogenic events. Methods: This multicentre international study included patients over 60 years undergoing PFO closure for cryptogenic thromboembolic events. A dedicated database compiled baseline, procedural, and follow-up data. Competing risk and adjusted outcome predictor analyses were conducted. Results: A total of 689 patients were included (median age 65 years, 41.2% female, mean Risk of Paradoxical Embolism [RoPE] score 4.5). The procedural success rate was 99.4%. After a median follow-up of 2 (interquartile range 1-5) years, 66 patients (9.6%) had died. CVE and stroke rates were 1.21 and 0.55 per 100 patient-years, respectively. Diabetes (hazard ratio [HR] 3.89, 95% confidence interval [CI]: 1.67-9.07; p=0.002) and atrial septal aneurysm (ASA; HR 5.25, 95% CI: 1.56-17.62; p=0.007) increased the CVE risk. New-onset AF occurred at a rate of 3.30 per 100 patient-years, with 51.3% within one month post-procedure. Older age (HR 1.05 per year, 95% CI: 1.00-1.09; p=0.023) and the absence of hypertension (HR 2.04, 95% CI: 1.19-3.57; p=0.010) were associated with an increased risk of AF. Conclusions: Older patients undergoing PFO closure had a relatively low rate of CVE and new-onset AF after a median follow-up of 2 years. The presence of diabetes, ASA, and a more advanced age determined an increased risk of adverse clinical events. These factors may be considered in the clinical decision-making process regarding PFO closure in this challenging population.